Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Daniel

Showing results (921-930 of 929) with videos related to

Pageof 93
Sort By:
You have reached the last page of results.This site can display upto 929 results.
Cancers|August 30, 2020
Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for OsteosarcomaPankita H Pandya, Lijun Cheng, M Reza Saadatzadeh, et al.
Nature Microbiology|April 21, 2025
An expanded metabolic pathway for androgen production by commensal bacteriaTaojun Wang, Saeed Ahmad, Angélica Cruz-Lebrón, et al.
Journal for Immunotherapy of Cancer|July 25, 2025
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumorsMohammed M Milhem, Trisha M Wise-Draper, Sunandana Chandra, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2023
Clinical consequences of a polygenic predisposition to benign lower white blood cell counts: Consequences of benign WBC count geneticsJonathan D Mosley, John P Shelley, Alyson L Dickson, et al.
Nature Communications|January 20, 2025
Construction and iterative redesign of synXVI a 903 kb synthetic Saccharomyces cerevisiae chromosomeHugh D Goold, Heinrich Kroukamp, Paige E Erpf, et al.
Cell Genomics|November 29, 2023
Parallel laboratory evolution and rational debugging reveal genomic plasticity to <i>S. cerevisiae</i> synthetic chromosome XIV defectsThomas C Williams, Heinrich Kroukamp, Xin Xu, et al.
Cancers|January 8, 2023
Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid TumorsPankita H Pandya, Asha Jacob Jannu, Khadijeh Bijangi-Vishehsaraei, et al.
Nature Communications|April 22, 2024
Clinical associations with a polygenic predisposition to benign lower white blood cell countsJonathan D Mosley, John P Shelley, Alyson L Dickson, et al.
Neoplasia (New York, N.Y.)|January 16, 2026
Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcomaFarinaz Barghi, M Reza Saadatzadeh, Erika A Dobrota, et al.
Pageof 93

Showing results (921-930 of 929) with videos related to

Sort By:
Pageof 93
You have reached the last page of results.This site can display upto 929 results.
Cancers|August 30, 2020
Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for OsteosarcomaPankita H Pandya, Lijun Cheng, M Reza Saadatzadeh, et al.
Nature Microbiology|April 21, 2025
An expanded metabolic pathway for androgen production by commensal bacteriaTaojun Wang, Saeed Ahmad, Angélica Cruz-Lebrón, et al.
Journal for Immunotherapy of Cancer|July 25, 2025
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumorsMohammed M Milhem, Trisha M Wise-Draper, Sunandana Chandra, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2023
Clinical consequences of a polygenic predisposition to benign lower white blood cell counts: Consequences of benign WBC count geneticsJonathan D Mosley, John P Shelley, Alyson L Dickson, et al.
Nature Communications|January 20, 2025
Construction and iterative redesign of synXVI a 903 kb synthetic Saccharomyces cerevisiae chromosomeHugh D Goold, Heinrich Kroukamp, Paige E Erpf, et al.
Cell Genomics|November 29, 2023
Parallel laboratory evolution and rational debugging reveal genomic plasticity to <i>S. cerevisiae</i> synthetic chromosome XIV defectsThomas C Williams, Heinrich Kroukamp, Xin Xu, et al.
Cancers|January 8, 2023
Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid TumorsPankita H Pandya, Asha Jacob Jannu, Khadijeh Bijangi-Vishehsaraei, et al.
Nature Communications|April 22, 2024
Clinical associations with a polygenic predisposition to benign lower white blood cell countsJonathan D Mosley, John P Shelley, Alyson L Dickson, et al.
Neoplasia (New York, N.Y.)|January 16, 2026
Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcomaFarinaz Barghi, M Reza Saadatzadeh, Erika A Dobrota, et al.
Pageof 93